CRS Recognition and Intervention: Timing and Clinical Features

Summary for Physicians:

Cytokine Release Syndrome (CRS) Recognition and Intervention

• CRS recognition:
• Commonly occurs within 24 to 48 hours post infusion.

• Symptoms include fever, chills, tachycardia, hypotension, dyspnea, and rash.
• Grading CRS:
• Grade 1: Mild fever and flulike symptoms, manageable with supportive care

• Grade 2: Moderate symptoms (eg, hypotension), requires medical intervention (eg, fluids, antipyretics)

• Grade 3: Severe symptoms (eg, hypoxia, multiorgan involvement), requires steroids and possibly tocilizumab

• Grade 4: Life-threatening, requires emergency management and intensive care unit care
• Intervention:
• Grade 1: Symptom management (eg, acetaminophen, hydration)

• Grade 2: Intravenous fluids, antipyretics, monitoring

• Grade 3/4: Corticosteroids, tocilizumab (IL-6 inhibitor), and intensive monitoring

Challenges:

Early recognition is crucial for effective management and preventing progression to severe CRS.